Today: 10 April 2026
Abercrombie & Fitch stock: what comes next after the 18% plunge on outlook update
13 January 2026
2 mins read

Abercrombie & Fitch stock: what comes next after the 18% plunge on outlook update

NEW YORK, Jan 13, 2026, 04:45 EST — Premarket

  • Shares of Abercrombie & Fitch held steady in premarket, following a sharp 17.7% drop on Monday that pushed the stock down to $102.78.
  • The retailer cut its full-year sales growth forecast while boosting its capital spending plan, citing tariff-related expenses.
  • Investors await further insights from management at the ICR Conference, particularly on the impact of tariffs on margins.

Abercrombie & Fitch (ANF.N) held steady near $102.78 in premarket Tuesday, following a sharp 17.7% drop the previous day. The stock closed Monday at $102.78, with roughly 6.6 million shares exchanged, after the company trimmed some of its guidance.

This shift matters today because the update didn’t signal falling demand — it flagged tighter economics. A small cut to sales growth, weaker margin forecasts, and ramped-up spending can easily unsettle a retail stock riding high on expectations.

The news came as retailers gathered with investors at the ICR Conference, a time when companies frequently trim guidance and the market digs for clues about the holiday season’s true impact. Traders are focused on whether pricing will turn more promotional and if cost pressures, rather than sales, will dominate the narrative heading into 2026.

Abercrombie cut its fiscal 2025 net sales growth forecast to at least 6%, down from the previous 6% to 7% range, according to an 8-K filing. The company now anticipates an operating margin near 13%, slightly below the prior 13.0% to 13.5% estimate. It left its full-year share repurchase plan steady at about $450 million but raised capital spending to roughly $245 million. Full-year earnings guidance tightened to a range of $10.30 to $10.40 per share. For Q4, Abercrombie projects net sales growth around 5% and earnings between $3.50 and $3.60 per share. CEO Fran Horowitz noted the company posted “record quarter-to-date net sales through fiscal December.” The forecast factors in roughly $90 million in tariff costs, which equate to about 170 basis points (1.7 percentage points) of sales after mitigation. SEC

Sentiment across the sector leaned cautious. American Eagle and Urban Outfitters both signaled slower holiday-quarter sales. Consumer Edge analyst Michael Gunther noted the “theme of value-seeking behavior was on full display in this morning’s slew of retail pre-announcements,” reflecting investor concerns over full-price sales and inventory control. Reuters

Abercrombie’s story flipped quickly—from “how high can growth climb” to “how solid are the margins.” The sales adjustment was minor, yet the margin cut and a clear tariff line caught sellers’ attention.

Some investors are betting on a rebound after the single-day selloff. Others want to see evidence the company can maintain pricing power even as it ramps up spending on stores and digital, without costs outpacing demand.

The downside is straightforward: if promotions ramp up after the holidays or tariffs shift again, that margin buffer could shrink fast. A more volatile consumer environment would only make it tougher to compensate through volume.

Insights will hinge on what management reveals — and leaves unsaid — during investor sessions at the ICR Conference running through Tuesday. Focus centers on tariff mitigation efforts and whether Q4 momentum persisted into January. With the fiscal year closing Jan. 31, all eyes are on the last stretch of results and upcoming guidance.

Stock Market Today

  • Korro Bio Announces Inducement Stock Grant Under Nasdaq Rule 5635(C)(4)
    April 10, 2026, 5:46 PM EDT. Korro Bio has reported an inducement grant under Nasdaq Listing Rule 5635(c)(4), which permits stock awards outside of shareholder approval as an incentive for new employees. The company aims to attract and retain key personnel through this equity award. Nasdaq Rule 5635(c)(4) allows such grants to compensate individuals without prior shareholder consent, reflecting Korro Bio's strategic hiring efforts amid competitive biotech market conditions. This move aligns with common practices among listed companies to offer stock-based incentives as recruitment tools.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 5:46 PM EDT Korro Bio Announces Inducement Stock Grant Under Nasdaq Rule 5635(C)(4) April 10, 2026, 5:46 PM EDT. Korro Bio has reported an inducement grant under Nasdaq Listing Rule 5635(c)(4), which permits stock awards outside of shareholder approval as an incentive for new employees. The company aims to attract and retain key personnel through this equity award. Nasdaq Rule 5635(c)(4) allows such grants to compensate individuals without prior shareholder consent, reflecting Korro Bio's strategic hiring efforts amid competitive biotech market conditions. This move aligns with common practices
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
ON Semiconductor stock slides before the open on CPI day: what investors watch next
Previous Story

ON Semiconductor stock slides before the open on CPI day: what investors watch next

JetBlue stock drops nearly 6% ahead of Tuesday open as credit-card cap talk and CPI data loom
Next Story

JetBlue stock drops nearly 6% ahead of Tuesday open as credit-card cap talk and CPI data loom

Go toTop